Lv2
148 积分 2024-04-11 加入
PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth
9小时前
已完结
An umbrella review of systematic reviews on the diagnostic and prognostic utility of circulating tumor DNA and MicroRNA in colorectal cancer
10天前
已完结
Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review
10天前
已完结
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers
10天前
已完结
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial
10天前
已完结
Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis
10天前
已完结
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma
10天前
已完结
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study
10天前
已完结
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
10天前
已完结
Discordance of HER2 expression in primary and recurrent/metastatic urothelial carcinoma in the upper tract
10天前
已完结
皖公网安备34019202002308
